ANÁLISIS SOCIODEMOGRÁFICO: TASA DE EGRESO HOSPITALARIO POR CÁNCER DE CUELLO UTERINO EN CHILE EN EL PERIODO 2019-2022.

Authors

  • Diego Ramos B Alumno, Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Talca, Chile.
  • Rodrigo Pino L Alumno, Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Talca, Chile.
  • Ignacio Almazan B Alumno, Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Talca, Chile.
  • Fernanda Neira Fuentes Alumno, Facultad de Medicina, Universidad de Concepción, Concepción, Chile.
  • Paula Aldunate González Médica Cirujana, Hospital del Carmen, Maipú, Chile.

Keywords:

Alta Hospitalaria, Neoplasias del Cuello Uterino, Virus del Papiloma Humano

Abstract

Introduction:

Cervical cancer (CaCu) stands as one of the primary malignancies among the female population. The aim of this study is to depict the hospital discharge rate (HDR) due to CaCu between the years 2019-2022 in Chile.

Materials and Methods:

A descriptive and cross-sectional study of the HDR for CaCu in Chile during the 2019-2022 period (n=7990). Data sourced from the Department of Statistics and Health Information of the Ministry of Health. Ethical committee approval was not required.

Results:

The HDR for the study period stood at 120.37 per 100,000 inhabitants, with the lowest HDR in the year 2020 at 26.51 per 100,000 inhabitants, and the highest HDR in the year 2019 at 34.89 per 100,000 inhabitants. The age group presenting the highest HDR is the 45-64 age bracket, with a rate of 139.01 per 100,000 inhabitants. The average length of hospital stay was 5.1 days.

Discussion:

The year with the highest HDR was 2019, and the year with the lowest HDR was 2020, which aligns with the onset of the SARS-CoV-2 pandemic and the resulting limitations on screening, diagnosis, and treatment.

The age group with the highest HDR is the 45-64 age bracket. This could be attributed to the initiation of Pap smear screening in Chile.

Regarding hospital stay days based on age group, the 20-44 age group exhibits the lowest count. This could be attributed to the lower prevalence of comorbidities in this group and the implementation of screening tests.

This kind of study is crucial for epidemiological characterization of this condition in Chile, enabling the evaluation of public policies developed to enhance the HDR for CaCu.

 

References

Zhang S, Xu H, Zhang L, Qiao Y. Cervical cancer: Epidemiology, risk factors and screening. Chinese Journal of Cancer Research [Internet]. 2020;32(6):720–8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33446995/

Abrahantes A, Oliver M, Gonzalez M, Rodriguez K, Muñoz O, Castro A. Cáncer cérvicouterino. Algo para reflexionar. Medisur [Internet]. 2020;17(6):857–66. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-897X2019000600857

Cohen P, Jhingran A, Oaknin A, Denny L. Cervical cancer. The Lancet, Seminar [Internet]. 2019; 393:169–82. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30638582/

Cardenas A, Campuzano B, Paredes J, Novillo M. Virus del papiloma humano y su relación con el cáncer de cérvix. RECIMUNDO [Internet]. 2022;6(2):346–54. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=8410265

Viquez K, Araya R, Hidalgo M. Cáncer de cérvix: generalidades. Revista Médica Sinergia. 2022;7(9): e898. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=8878289

World Heart Organization. The Global Cancer Observatory [Internet]. GLOBOCAN. 2020 [citado el 6 de junio de 2023]. Disponible en: https://gco.iarc.fr/today/data/factsheets/cancers/23-Cervix-uteri-fact-sheet.pdf

Grupo de reactivación sanitaria, Colegio Médico de Chile, editor. El impacto del COVID 19 en el sistema de salud y propuestas para la reactivación [Internet]. Vol. 1. Colegio Médico de Chile; 2020. Disponible en: https://www.colegiomedico.cl/wp-content/uploads/2020/08/reactivacion-sanitaria.pdf

Minsal. Cáncer cervicouterino [Internet]. Guías clínicas AUGE. 2015 [citado el 6 de junio de 2023]. Disponible en: https://www.minsal.cl/wp-content/uploads/2015/09/GPC-CaCU.pdf

Aldunate M. Vacuna virus papiloma humano. Beneficios y seguridad en su uso [Internet]. Instituto de Salud Pública; 2019. [citado el 6 de junio de 2023] Disponible en: https://www.ispch.cl/newsfarmacovacunas/03/images/03vigilancia.pdf

Vega A, Ávila M, GongoraC. Principales factores de riesgo en la tercera edad: su prevención. Didasc@lia: didáctica y educación [Internet]. 2021 [citado el 12 de agosto de 2023];12(1):147–57. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=7909860

Published

2024-10-24

How to Cite

1.
Ramos B D, Pino L R, Almazan B I, Neira Fuentes F, Aldunate González P. ANÁLISIS SOCIODEMOGRÁFICO: TASA DE EGRESO HOSPITALARIO POR CÁNCER DE CUELLO UTERINO EN CHILE EN EL PERIODO 2019-2022. Rev Estud Med Sur [Internet]. 2024 Oct. 24 [cited 2025 Oct. 14];10(2). Available from: https://rems.ufro.cl/index.php/rems/article/view/204

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)